The estimated prevalence of patients in the United States with short bowel syndrome (SBS) is 2 per million people. SBS patients have complex nutritional requirements due to the loss of absorptive capacity. Based upon a patient’s remaining gastrointestinal anatomy, dramatic changes may occur in fluid, electrolyte, and trace element nutriture. The combination of diet, medications, and growth factors can also allow SBS patients requiring home parenteral nutrition to reduce or eliminate their dependency on this therapy. With the appropriate indications, surgical procedures including intestinal transplantation may be a therapeutic option for patients with SBS and intestinal failure. This program will provide the attendee with knowledge of recent advances in pharmacotherapy, nutrition support, and surgical options for SBS patients.
MBBS, FRCS, FACS,
Professor of Surgery and Pediatrics, Mount Sinai School of Medicine; Director of Adult and Pediatric Intestinal Rehabilitation & Transplantation; Surgical Director of Pediatric Liver Transplantation,
Mount Sinai Medical Center, New York, NY
PhD, RDN, LDN, CNSC, FADA, FASPEN, FAND,
Professor of Medicine,
Department of Internal Medicine, Brody School of Medicine, East Carolina University, Greenville, North Carolina